↓ Skip to main content

Cochrane Database of Systematic Reviews

Long-acting beta2-agonists for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
30 tweeters
facebook
1 Facebook page
googleplus
2 Google+ users

Citations

dimensions_citation
105 Dimensions

Readers on

mendeley
251 Mendeley
Title
Long-acting beta2-agonists for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd010177.pub2
Pubmed ID
Authors

Kayleigh M Kew, Chris Mavergames, Julia AE Walters

Abstract

Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up. It is the fourth or fifth most common cause of death worldwide and is associated with significant healthcare costs.Inhaled long-acting beta2-agonists (LABAs) are widely prescribed to manage the symptoms of COPD when short-acting agents alone are no longer sufficient. Twice-daily treatment with an inhaled LABA is aimed at relieving symptoms, improving exercise tolerance and quality of life, slowing decline and even improving lung function and preventing and treating exacerbations.

Twitter Demographics

The data shown below were collected from the profiles of 30 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 251 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
United States 1 <1%
Netherlands 1 <1%
South Africa 1 <1%
Unknown 246 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 42 17%
Student > Ph. D. Student 30 12%
Researcher 30 12%
Student > Bachelor 28 11%
Other 22 9%
Other 53 21%
Unknown 46 18%
Readers by discipline Count As %
Medicine and Dentistry 110 44%
Nursing and Health Professions 21 8%
Pharmacology, Toxicology and Pharmaceutical Science 14 6%
Social Sciences 13 5%
Psychology 12 5%
Other 28 11%
Unknown 53 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2020.
All research outputs
#680,437
of 18,659,856 outputs
Outputs from Cochrane database of systematic reviews
#1,635
of 11,841 outputs
Outputs of similar age
#7,300
of 182,656 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 101 outputs
Altmetric has tracked 18,659,856 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,841 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,656 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.